Ledger.Open graph →
SEC Form D · filed April 14, 2022

Salish Bioscience Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Frank Paganelli · Seattle, WAExec · DirectorChris Raymond · Seattle, WADirectorKira Misura · Seattle, WADirectorFenella Raymond · Seattle, WAExec · DirectorFrank Paganelli · Carnation, WAExec · DirectorChris Raymond · Seattle, WADirectorKira Misura · Seattle, WADirectorFenella Raymond · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗